Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.,Clinical Infectious Diseases

当前位置： X-MOL 学术 › Clin. Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2020-04-07 , DOI: 10.1093/cid/ciaa394
Sophie Perinel _{1,

2} , Manon Launay ₃ , Élisabeth Botelho-Nevers ₄ , Éric Diconne ₁ , Aurore Louf-Durier ₁ , Raphaël Lachand ₁ , Martin Murgier ₁ , Dominique Page ₁ , Régine Vermesch ₁ , Guillaume Thierry ₁ , Xavier Delavenne _{2,

3}

Affiliation

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.

中文翻译：